Literature DB >> 18438847

Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction.

B J Emmer1, G M Steup-Beekman, S C A Steens, T W J Huizinga, M A van Buchem, J van der Grond.   

Abstract

OBJECTIVE: To investigate whether, in neuropsychiatric systemic lupus erythematosus (NPSLE) patients, magnetization transfer ratio (MTR) histogram parameters are related to neurochemical findings obtained using proton magnetic resonance spectroscopy (1H-MRS) and to determine whether MTR histogram changes are linked to specific SLE and NPSLE characteristics.
METHODS: Eighteen SLE patients (15 female, 3 male; mean +/- SD age 42.8 +/- 12.8 years), 34 NPSLE patients (32 female, 2 male; mean +/- SD age 35.9 +/- 12.2 years), and 15 healthy controls (14 female, 1 male; mean +/- SD age 44.7 +/- 9.6 years) underwent magnetization transfer imaging and 1H-MRS. Whole-brain MTR histogram parameters were associated with 1H-MRS metabolite ratios, certain SLE criteria, and neuropsychiatric syndromes.
RESULTS: No differences were found in the MTR histogram parameters between SLE patients and NPSLE patients. NPSLE patients had a lower MTR histogram peak height than did the healthy controls. The MTR histogram peak height and the mean height were significantly associated with the N-acetylaspartate to creatinine ratio, suggesting neuronal dysfunction. Of all SLE criteria, renal dysfunction and arthritis were associated with MTR histogram parameters. After corrections for age, sex, and these SLE criteria, of the various neuropsychiatric syndromes only cognitive dysfunction was associated with the MTR histogram peak height.
CONCLUSION: The MTR peak height is lower in NPSLE patients than in healthy controls. MTR peak height reflects neuronal dysfunction, as detected by 1H-MRS. Furthermore, the MTR peak height is associated with cognitive dysfunction but not with the other neuropsychiatric syndromes evaluated in our study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438847     DOI: 10.1002/art.23452

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  11 in total

Review 1.  Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations.

Authors:  George K Bertsias; Dimitrios T Boumpas
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Localization of cerebral functional deficits in patients with non-neuropsychiatric systemic lupus erythematosus.

Authors:  Yun Lin; Qing-Hua Zou; Jian Wang; Yong Wang; Dai-Quan Zhou; Rong-Hua Zhang; Yan-Wei Zhang; Hai-Tao Lii; Yong-Fei Fang
Journal:  Hum Brain Mapp       Date:  2010-12-17       Impact factor: 5.038

3.  Glial and axonal changes in systemic lupus erythematosus measured with diffusion of intracellular metabolites.

Authors:  Ece Ercan; Cesar Magro-Checa; Romain Valabregue; Francesca Branzoli; Emily T Wood; Gerda M Steup-Beekman; Andrew G Webb; Tom W J Huizinga; Mark A van Buchem; Itamar Ronen
Journal:  Brain       Date:  2016-03-11       Impact factor: 13.501

Review 4.  Neurocognitive impairment in children and adolescents with systemic lupus erythematosus.

Authors:  Deborah M Levy; Stacy P Ardoin; Laura E Schanberg
Journal:  Nat Clin Pract Rheumatol       Date:  2009-02

5.  Quantitative neuroimaging advances in the measurement of brain injury but not brain function in systemic lupus erythematosus.

Authors:  Bruce T Volpe; Cynthia Aranow; Meggan Mackay
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

Review 6.  Neuropsychiatric systemic lupus erythematosus: pathogenesis and biomarkers.

Authors:  Hélène Jeltsch-David; Sylviane Muller
Journal:  Nat Rev Neurol       Date:  2014-09-09       Impact factor: 42.937

Review 7.  Cognitive Dysfunction in Systemic Lupus Erythematosus: Immunopathology, Clinical Manifestations, Neuroimaging and Management.

Authors:  Dominic Seet; Nur Azizah Allameen; Jiacai Cho; Anselm Mak; Sen Hee Tay
Journal:  Rheumatol Ther       Date:  2021-05-15

8.  A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus.

Authors:  Ece Ercan; Carson Ingo; Oranan Tritanon; Cesar Magro-Checa; Alex Smith; Seth Smith; Tom Huizinga; Mark A van Buchem; Itamar Ronen
Journal:  Neuroimage Clin       Date:  2015-05-16       Impact factor: 4.881

9.  Magnetization transfer imaging in 'premanifest' Huntington's disease.

Authors:  Caroline K Jurgens; Reineke Bos; Jasper Luyendijk; Marie-Noëlle W Witjes-Ané; Jeroen van der Grond; Huub A M Middelkoop; Raymund A C Roos
Journal:  J Neurol       Date:  2009-10-13       Impact factor: 4.849

Review 10.  Advanced and Conventional Magnetic Resonance Imaging in Neuropsychiatric Lupus.

Authors:  Nicolae Sarbu; Núria Bargalló; Ricard Cervera
Journal:  F1000Res       Date:  2015-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.